Francesco Locatelli

Francesco Locatelli's AcademicInfluence.com Rankings

Francesco Locatelli

Economics

#2330

World Rank

#2664

Historical Rank

Microeconomics

#58

World Rank

#62

Historical Rank

economics Degrees

Download Badge

Economics

Francesco Locatelli's Degrees

PhD Economics University of Milan
Masters Economics University of Milan
Bachelors Economics University of Milan

Similar Degrees You Can Earn

Why Is Francesco Locatelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Francesco Locatelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia. (2006) (2033)
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency (1996) (1606)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. (2004) (1045)
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. (2004) (873)
Effect of dialysis dose and membrane flux in maintenance hemodialysis. (2003) (810)
Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2003) (780)
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. (2001) (776)
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. (2003) (748)
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. (1996) (538)
Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. (2011) (523)
The burden of kidney disease: improving global outcomes. (2004) (501)
RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE (1995) (493)
Corticosteroids in IgA nephropathy: a randomised controlled trial (1999) (460)
Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. (2004) (441)
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2004) (427)
Pure red-cell aplasia and epoetin therapy. (2004) (423)
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy (2003) (404)
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2004) (393)
Effect of membrane permeability on survival of hemodialysis patients. (2009) (382)
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. (2005) (372)
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. (1995) (352)
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. (2013) (348)
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. (1999) (338)
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2004) (337)
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. (2005) (332)
Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. (2003) (303)
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute (2007) (275)
Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. (1996) (262)
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. (2010) (247)
Nutritional status in dialysis patients: a European consensus. (2002) (244)
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. (2008) (231)
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. (2002) (227)
Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. (1999) (226)
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management (2014) (218)
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial (2017) (213)
Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2004) (209)
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency (1991) (207)
Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. (2001) (206)
Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). (2008) (205)
Predictors of outcome in Henoch-Schönlein nephritis in children and adults. (2006) (204)
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome (1993) (202)
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation (2017) (198)
Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. (1996) (192)
Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. (2016) (188)
Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. (2000) (183)
The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. (2004) (179)
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation (2011) (173)
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party (2005) (173)
Renal replacement therapy in patients with diabetes and end-stage renal disease. (2004) (172)
Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. (1996) (169)
The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry. (1998) (167)
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. (2015) (166)
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. (2006) (165)
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. (2019) (162)
Renal manifestations in the metabolic syndrome. (2006) (162)
Searching for alternative hematopoietic stem cell donors for pediatric patients (2008) (158)
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. (2001) (158)
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. (2010) (151)
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. (2001) (149)
Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. (2007) (148)
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. (1996) (148)
Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. (2001) (147)
Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010 (2016) (144)
The importance of early detection of chronic kidney disease. (2002) (139)
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. (2010) (137)
Use of phosphate-binding agents is associated with a lower risk of mortality. (2013) (135)
Epidemiology of cardiovascular risk in patients with chronic kidney disease. (2003) (133)
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. (2015) (131)
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (2008) (129)
Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. (2000) (125)
Human Mesenchymal Stem Cells Derived from Bone Marrow Display a Better Chondrogenic Differentiation Compared with Other Sources (2007) (123)
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. (2009) (123)
Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. (1996) (123)
Haemodialysis with on-line monitoring equipment: tools or toys? (2005) (122)
Dialysis dose and frequency. (2005) (122)
The epidemiology of end-stage renal disease in Iran in an international perspective. (2002) (120)
Clinical Evidence on Hemodiafiltration: A Systematic Review and a Meta‐analysis (2014) (118)
Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. (2001) (115)
Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. (2009) (115)
Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo). (2003) (112)
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2017) (111)
Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membrane. (2005) (110)
Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. (1997) (109)
What We Know About Oxidative Stress in Patients with Chronic Kidney Disease on Dialysis—Clinical Effects, Potential Treatment, and Prevention (2011) (108)
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. (2010) (108)
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient (2011) (108)
Photopheresis in paediatric patients with drug‐resistant chronic graft‐versus‐host disease (1997) (107)
Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. (2006) (105)
Morbidity and Mortality on Maintenance Haemodialysis (1998) (103)
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. (2004) (102)
Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management (2015) (101)
The role of blood volume reduction in the genesis of intradialytic hypotension. (2002) (101)
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors (2002) (100)
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. (2005) (98)
C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. (2008) (98)
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2013) (97)
Nutritional treatment of advanced CKD: twenty consensus statements (2018) (95)
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients (2017) (95)
Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size. (2016) (94)
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia (2015) (93)
Kidney and liver involvement in monoclonal light chain disorders. (2002) (91)
Optimal composition of the dialysate, with emphasis on its influence on blood pressure. (2004) (91)
Comparative testing and pharmacovigilance of biosimilars. (2006) (89)
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) (89)
Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols (2005) (88)
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML) (2004) (88)
New Treatment Approaches for the Anemia of CKD. (2016) (84)
Low-protein diets for chronic kidney disease patients: the Italian experience (2016) (83)
Peginesatide in patients with anemia undergoing hemodialysis. (2013) (83)
The quality of dialysis water. (2003) (81)
Hypertension and cardiovascular risk assessment in dialysis patients. (2004) (80)
Effect of high-flux dialysis on the anaemia of haemodialysis patients. (2000) (80)
COSMOS: the dialysis scenario of CKD-MBD in Europe. (2013) (80)
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? (2004) (79)
Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis. (1996) (79)
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial (2010) (78)
Unrelated donor stem cell transplantation in adult patients with thalassemia (2005) (76)
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia (2005) (76)
Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study. (2002) (75)
Hemodialysis vascular access training and practices are key to improved access outcomes. (2010) (74)
Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (2015) (73)
High-flux versus low-flux membranes for end-stage kidney disease. (2012) (72)
Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. (1997) (71)
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study (2008) (71)
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). (2008) (70)
Practical guidelines for the use of NESP in treating renal anaemia. (2001) (70)
Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. (1998) (70)
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis. (2016) (70)
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs (1998) (70)
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) (2014) (69)
The importance of diabetic nephropathy in current nephrological practice. (2003) (69)
The importance of convective transport. (2002) (66)
Hyperinsulinemia in children and adolescents after bone marrow transplantation. (1995) (66)
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. (2013) (65)
Mortality risk in patients on hemodiafiltration versus hemodialysis: a ‘real-world’ comparison from the DOPPS (2017) (61)
The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome (2009) (61)
Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. (1997) (60)
Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration* (2007) (59)
Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. (1983) (59)
Kidney and liver involvement in cryoglobulinemia. (2002) (58)
Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference. (2021) (58)
Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood (2007) (57)
Effect of on-line conductivity plasma ultrafiltrate kinetic modeling on cardiovascular stability of hemodialysis patients. (1998) (56)
Monitoring Sodium Removal and Delivered Dialysis by Conductivity (1995) (56)
Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation. (2006) (56)
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. (2013) (55)
Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children (2000) (55)
Prognosis of diabetic patients on dialysis: analysis of Lombardy Registry data. (1995) (55)
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. (2011) (55)
Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles (2014) (55)
Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. (1994) (55)
Safety concerns about intravenous iron therapy in patients with chronic kidney disease (2016) (55)
Renal disease and patient survival in light chain deposition disease. (1995) (54)
Inflammation and resistance to treatment with recombinant human erythropoietin. (2005) (54)
Pure Red-Cell Aplasia “Epidemic”—Mystery Completely Revealed? (2007) (54)
Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. (1994) (53)
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation (2007) (53)
Update on extracorporeal photochemotherapy for graft-versus-host disease treatment (2005) (53)
Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices. (2011) (53)
Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. (1996) (52)
Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls. (2018) (52)
The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial. (1999) (51)
Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. (1994) (51)
Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis (2012) (51)
Optimizing haemodialysate composition (2015) (50)
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial. (2004) (50)
The regulatory framework of biosimilars in the European Union. (2012) (50)
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia (2007) (50)
1983 to 1992: report on regular dialysis and transplantation in Lombardy. (1995) (49)
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
Removal of small and middle molecules by convective techniques. (2000) (47)
Mortality reduction by post‐dilution online‐haemodiafiltration: a cause‐specific analysis (2016) (47)
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study. (2015) (47)
Relevance of the conductivity kinetic model in the control of sodium pool. (2000) (47)
Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: a long-term prospective evaluation. (2006) (46)
Expression of G1-phase cell cycle genes during hematopoietic lineage. (1997) (46)
Remissions and relapses in idiopathic membranous nephropathy. (1992) (46)
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. (2007) (46)
Dietary Management of Incremental Transition to Dialysis Therapy: Once-Weekly Hemodialysis Combined With Low-Protein Diet. (2016) (46)
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations (2014) (45)
Ionic dialysance as a method for the on-line monitoring of delivered dialysis without blood sampling. (1996) (45)
Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint. (2003) (45)
Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. (1993) (45)
Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group. (1998) (45)
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. (2013) (44)
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis (2011) (44)
Myelodysplastic syndromes: the pediatric point of view. (1995) (43)
Dialysis adequacy today: a European perspective. (2012) (43)
Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies (2013) (43)
'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study. (1997) (42)
Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II) (2001) (42)
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial (2012) (42)
The growing problem of intradialytic hypertension (2010) (41)
Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia. (1996) (41)
Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. (1994) (41)
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality (2007) (41)
Sodium modeling in hemodiafiltration. (1991) (41)
Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. (1997) (41)
Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease. (2003) (40)
Hepatitis E virus infection in haemodialysis patients: a seroepidemiological survey. (1997) (40)
Long-term outcome in hemodialysis: morbidity and mortality. (2004) (40)
Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. (1999) (39)
Hypertension in dialysis: pathophysiology and treatment. (2002) (39)
Color doppler ultrasonography imaging to guide transluminal angioplasty of venous stenosis. (2000) (39)
Long-term bone marrow cultures in Diamond-Blackfan anemia reveal a defect of both granulomacrophage and erythroid progenitors. (1999) (39)
CORD BLOOD TRANSPLANTATION (CBT) IN HEMOGLOBINOPATHIES (1998) (39)
How to determine ionic dialysance for the online assessment of delivered dialysis dose. (2001) (39)
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO). (1997) (39)
On-line assessment of delivered dialysis dose Technical Note (1998) (38)
C.E.R.A.: pharmacodynamics, pharmacokinetics and efficacy in patients with chronic kidney disease (2007) (38)
On the safety of intravenous iron, evidence trumps conjecture (2015) (38)
Supplemented low-protein diet and once-weekly hemodialysis. (1994) (38)
Antiphospholipid (aPL) antibodies in end-stage renal disease. (1999) (38)
An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease (2016) (38)
Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. (2001) (37)
Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group. (1999) (37)
Editorials: Sodium Balance in Hemodialysis Therapy (2003) (37)
Survival of Prosthetic Grafts of Different Materials after Impairment of a Native Arteriovenous Fistula in Hemodialysis Patients (2001) (37)
The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia (2007) (37)
Convection versus diffusion in dialysis: an Italian prospective multicentre study. (2003) (36)
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics. (2018) (35)
How long can dialysis be postponed by low protein diet and ACE inhibitors? (1999) (35)
Simultaneous measurement of peritoneal glucose and free water osmotic conductances. (2007) (35)
MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study (2011) (35)
Automatic adaptive system dialysis for hemodialysis-associated hypotension and intolerance: a noncontrolled multicenter trial. (2011) (34)
Sodium kinetics across dialysis membranes. (1984) (34)
Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl. (2012) (34)
Latest US KDOQI Anaemia Guidelines update--what are the implications for Europe? (2007) (34)
Dialysis adequacy and response to erythropoietic agents: what is the evidence base? (2003) (33)
Pure red cell aplasia secondary to treatment with erythropoietin. (2003) (33)
A Randomized Trial on Health-Related Patient Satisfaction Level with High-Efficiency Online Hemodiafiltration versus High-Flux Dialysis (2015) (33)
European results of unrelated cord blood transplants (1998) (33)
The MPO Study: Just a European HEMO Study or Something Very Different? (2008) (33)
Determining the adequacy of sodium balance in hemodialysis using a kinetic model. (1996) (33)
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia (2013) (32)
International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study. (2016) (32)
Biosimilars and Regulatory Authorities (2010) (32)
Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial. (1999) (32)
Ten years experience of renal replacement treatment in the elderly. (1997) (31)
Effect of Synthetic Vitamin E-Bonded Membrane on Responsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Pilot Study (2010) (31)
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol (2016) (31)
Toxicity in man due to stain removers containing 1,2-dichloropropane. (1985) (31)
Roxadustat in the treatment of anaemia in chronic kidney disease (2018) (31)
Dialysis patient outcomes in Europe vs the USA. Why do Europeans live longer? (1997) (31)
Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients. (1997) (30)
Anemia and cardiovascular risk: the lesson of the CREATE Trial. (2006) (30)
Ionic dialysance as a method for the on-line monitoring of delivered dialysis without blood sampling (1996) (30)
Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease (2018) (30)
Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma. (1998) (30)
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol (2017) (30)
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO). (2001) (29)
Optimizing dose and mode of renal replacement therapy in anaemia management. (2002) (29)
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). (2008) (29)
Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? (2006) (29)
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group (2017) (29)
Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes. (2013) (28)
Erythropoiesis-stimulating agents in renal medicine. (2011) (28)
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission (2003) (28)
Optimization of sodium removal in paired filtration dialysis by single pool sodium and conductivity kinetic models. (1997) (28)
Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms (2014) (28)
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study (2013) (28)
Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO). (1996) (28)
Overfill of Peritoneal Dialysis Bags as a Cause of Underestimation of Ultrafiltration Failure (2006) (27)
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study. (2010) (27)
Sodium removal and sodium concentration during peritoneal dialysis: effects of three methods of sodium measurement. (2004) (27)
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis (2014) (27)
Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues (2006) (27)
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial. (2013) (27)
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol (2015) (27)
C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease. (2010) (26)
Inhibition of the Renin-Angiotensin System in Chronic Kidney Disease: A Critical Look to Single and Dual Blockade (2009) (26)
Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. (1998) (26)
Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye’s Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR) (2012) (26)
An expert opinion on the current treatment of anemia in patients with kidney disease (2012) (26)
Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies (2014) (26)
Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. (1998) (26)
Electrolyte disorders and substitution fluid in continuous renal replacement therapy. (1998) (25)
IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors (2006) (25)
Increasing home based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis (2011) (25)
Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation (2007) (25)
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group (2017) (25)
Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia (2007) (25)
Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia (1999) (25)
Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease. The Northern Italian Cooperative Study Group. (1995) (24)
Duration of dialysis sessions--was Hegel right? (1999) (24)
The epidemiology of end-stage renal disease in the Baltic countries: an evolving picture. (2001) (24)
Patient selection affects end-stage renal disease outcome comparisons (2000) (24)
ROLE OF PROTEINURIA REDUCTION IN THE PROGRESSION OF IgA NEPHROPATHY (2001) (24)
Hemodialysis: yesterday, today and tomorrow. (2010) (24)
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia (2013) (24)
Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group. (1992) (24)
Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. (2004) (24)
Sodium and Dialysis: A Deeper Insight (1989) (23)
Spurious estimations of sodium removal during CAPD when [Na](+) is measured by Na electrode methodology. (2000) (23)
Recombinant human epoetin beta in the treatment of renal anemia (2007) (23)
Chronic kidney disease-associated anemia: new remedies. (2010) (23)
Current and potential treatment options for hyperphosphatemia (2018) (22)
Ultrafiltration and high sodium concentration dialysis: pathophysiological correlation. (1978) (22)
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients. (2018) (22)
Progress in dialysis technology: membrane selection and patient outcome. (2000) (22)
Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study (2012) (22)
The need for better control of secondary hyperparathyroidism. (2004) (22)
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the AIEOP AML-2002/01 study (2015) (21)
Nephrology: main advances in the last 40 years. (2006) (21)
Allogeneic stem cell transplantation for Fanconi anaemia (1998) (21)
Molecular epidemiology of hepatitis C virus infection in dialysis patients. (1997) (21)
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS (2014) (21)
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19 (2020) (21)
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy. (2015) (21)
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]. (2004) (20)
Translocation (8;21) in two cases of refractory anemia with excess of blasts in transformation. (1992) (20)
Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies? (2002) (20)
Unrelated donor marrow transplantation for inborn errors. (1998) (20)
Iron Therapy Challenges for the Treatment of Nondialysis CKD Patients. (2016) (20)
Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis (2016) (20)
Relationship between urea clearance and ionic dialysance determined using a single-step conductivity profile. (2005) (20)
Sodium removal during pre-dilution haemofiltration. (2003) (20)
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donors. (1996) (20)
Haemodialysis or haemodiafiltration: that is the question (2018) (20)
How Can Prognosis for Diabetic ESRD Be Improved? (2010) (20)
Lanthanum carbonate (Shire). (2003) (19)
Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease (2014) (19)
Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT (2008) (19)
The role of underlying nephropathy in the progression of renal disease. (2000) (19)
The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia (2010) (19)
Epidemiology of chronic kidney disease in Italy: possible therapeutical approaches. (2003) (19)
«Physiological» and «Pharmacological» Dialysate Sodium Concentrations (1982) (19)
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party. (1996) (19)
Optimizing the management of renal anemia: challenges and new opportunities. (2008) (18)
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. (2019) (18)
Pathochemical toxicity of perfluorocarbon-5070, a liquid test performance fluid previously used in dialyzer manufacturing, confirmed in animal experiment. (2005) (18)
Effectiveness of sodium and conductivity kinetic models in predicting end‐dialysis plasma water sodium concentration: Preliminary results of a single‐center experience (2007) (18)
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood (2013) (18)
The patient with IgA glomerulonephritis--what is the role of steroid treatment? (1999) (18)
Factors affecting progression of renal insufficiency. (1997) (18)
Ionic dialysance allows an adequate estimate of urea distribution volume in hemodialysis patients. (2004) (18)
Difficulties of implementing clinical guidelines in medical practice. (2000) (18)
Cancer in patients on renal replacement therapy in Lombardy, Italy (1996) (18)
ACE inhibitors and angiotensin II receptor blockers in IgA nephropathy with mild proteinuria: the ACEARB study. (2006) (17)
Corticosteroids in IgA nephropathy (1999) (17)
Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (2017) (17)
Erratum: Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Nephrology Dialysis Transplantation (2004) vol. 19 (121-132) 10.1093/ndt/gfh314) (2004) (17)
Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma. (1980) (17)
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial. (2019) (17)
Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results. (2009) (17)
Hepatitis C virus genotypes in chronic dialysis patients. (1996) (17)
Preservation of residual renal function in peritoneal dialysis patients: still a dream? (2008) (17)
Changes in the clinical condition of haemodialysis patients. (1999) (17)
CKD Patients: The Dilemma of Serum PTH Levels (2010) (17)
Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial. (2014) (16)
IgA nephritis: ACE inhibitors, steroids, both or neither? (2006) (16)
Biocompatibility in haemodialysis: fact and fiction (1997) (16)
Clinical policies on the management of chronic kidney disease patients in Italy. (2007) (16)
On-line assessment of delivered dialysis dose. (1998) (16)
Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study. (1995) (16)
Sodium Kinetics During Dialysis (1999) (16)
Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients. (1996) (15)
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis (2014) (15)
Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study (2017) (15)
Can convective therapies improve dialysis outcomes? (2009) (15)
The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP) (2009) (15)
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia : where are we now and where do we go from here ? (2004) (15)
Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors. (1999) (15)
RELAPSING HAEMOLYTIC-URAEMIC SYNDROME AFTER ORGANIC SOLVENT SNIFFING (1983) (15)
A new initiative in nephrology: 'Kidney disease: improving global outcomes'. (2005) (15)
Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter? (2014) (15)
Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCR (2007) (15)
Anemia and heart failure in chronic kidney disease. (2005) (14)
ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data. (2008) (14)
Antiproteinuric effect of losartan in patients with chronic renal diseases. (1997) (14)
Recombinant human G-CSF: how wide is the field of clinical applicability? (1995) (14)
Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection. (2002) (14)
Geriatric Nephrology (1984) (14)
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). (2020) (14)
Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial (2017) (14)
Mortality and Cardiovascular Morbidity Associated with Haemoglobin Levels: A Pooled Analysis of Randomised Controlled Trials (2014) (14)
Is nephrology more at ease than oncology with erythropoiesis-stimulating agents? Treatment guidelines and an update on benefits and risks. (2009) (14)
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia (2007) (13)
New treatment approaches in chronic kidney disease-associated anaemia (2014) (13)
Dry weight and sodium balance. (2001) (13)
Hemodiafiltration - state of the art. (2011) (13)
Clinical validation of glucose pump test (GPT) compared with ultrasound dilution technology in arteriovenous graft surveillance. (2004) (13)
Oral cinacalcet HCI (AMG 073) for the treatment of hemodialysis patients with secondary hyperparathyroidism (HPT): Results of a European/Australian-Phase 3 study (2003) (13)
Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment. (2010) (13)
Update on anemia management in nephrology, including current guidelines on the use of erythropoiesis-stimulating agents and implications of the introduction of "biosimilars". (2009) (13)
Nutritional Issues with Incremental Dialysis: The Role of Low‐Protein Diets (2017) (13)
Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases (1998) (13)
Ethical issues in the elderly with renal disease. (2009) (13)
Treatment modalities in comparison: when do clinical differences emerge? (2000) (13)
The renoprotective effect of antihypertensive drugs. (1998) (13)
Ph-positive CML in blastic phase with monosomy 7 in a Down syndrome patient. Monitoring by interphase cytogenetics and demonstration of maternal allelic loss. (1997) (12)
Clinical benefits of slowing the progression of renal failure. (2005) (12)
Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study (2020) (12)
High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation (2001) (12)
Dialysis: its role in optimizing recombinant erythropoietin treatment. (2001) (12)
Dialysis adequacy and response to erythropoiesis-stimulating agents: what is the evidence base? (2006) (12)
Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients. (2004) (12)
Color Doppler Ultrasonography Percutaneous Transluminal Angioplasty of Vascular Access Grafts (2007) (12)
Postdialysis Hypertension: Associated Factors, Patient Profiles, and Cardiovascular Mortality. (2016) (12)
Uraemic toxins versus volume and water as the major factor that matters with dialysis. (2012) (12)
Arteriovenous fistula as a nephroprotective intervention in advanced CKD: scientific discovery and explanation, and the evaluation of interventions. (2015) (12)
Efficiency in hemodialysis with polyethersulfone membrane (DIAPES). (2003) (12)
Conductivity: On-Line Monitoring of Dialysis Adequacy (1998) (12)
Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients. (2008) (11)
Dialysis: History, Development and Promise (2013) (11)
New erythropoiesis-stimulating agents and new iron formulations. (2011) (11)
Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease (2012) (11)
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO). (2000) (11)
Darbepoetin alfa and chronic kidney disease. (2010) (11)
Are all erythropoiesis-stimulating agents created equal? (2020) (11)
Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis. (2009) (11)
Increasing home‐based dialysis therapies to tackle dialysis burden around the world: A position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis (2011) (11)
Hematide™ for the treatment of chronic kidney disease-related anemia (2009) (11)
Renal Anemia: Comparing Current Eastern and Western European Management Practice (ORAMA) (2008) (11)
Assessment of human herpesvirus‐6 infection in mesenchymal stromal cells ex vivo expanded for clinical use (2009) (11)
Comparison of hemodialysis, hemodiafiltration, and hemofiltration: systematic review or systematic error? (2005) (11)
Current Evidence in Haemodiafiltration (2015) (11)
Assessment of intradialysis calcium mass balance by a single pool variable‐volume calcium kinetic model (2017) (11)
Recent trials on hemodiafiltration. (2011) (10)
Is it the agent or the blood pressure level that matters for renal and vascular protection in chronic nephropathies? (2005) (10)
Cord blood transplantation for children with acute leukemia. Eurocord Transplant Group. (1998) (10)
Efficacy and safety of once-monthly continuous erythropoietin receptor activator in patients with chronic renal anemia. (2013) (10)
Hepatitis C virus genotypes in chronic dialysis patients (1996) (10)
[Italian study on the treatment of anaemia in chronic dialysis patients switched over to less frequent doses of darbepoetin from human recombinant erythropoietin (rHuEPO)]. (2004) (10)
On-line monitoring and convective treatment modalities: short-term advantages. (1999) (10)
Current and future chemical therapies for treating anaemia in chronic kidney disease (2017) (10)
Protein restriction: a revisited old strategy with new opportunities? (2014) (10)
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS (2014) (10)
Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial. (1996) (10)
REIN follow-up trial (1998) (10)
Integrated diet and dialysis programme. (1998) (10)
Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star? (2013) (9)
Colour Doppler twinkling in kidney stones: artefact or sign? (2010) (9)
Can Immunosuppressive Therapy Be Useful in IgA Nephropathy when the ‘Point of No Return’ Has Already Been Exceeded? (2002) (9)
Effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on small cell lung cancer cells. (1994) (9)
Improving the outcome of dialysis--opinion vs scientific evidence. Report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 6 September 1999, Madrid. (2000) (9)
Hypertension and chronic renal insufficiency: the experience of the Northern Italian Cooperative Study Group. (1993) (9)
Hepatitis C virus infection and hepatic function in chronic hemodialysis patients. (1992) (9)
The Relationship of NT-proBNP and Dialysis Parameters with Outcome of Incident Haemodialysis Patients: Results from the Membrane Permeability Outcome Study (2013) (9)
Methoxypolyethylene glycol-epoetin beta for the treatment of anemia associated with chronic kidney disease. (2008) (9)
Erythropoietic response to erythropoiesis-stimulating agents and outcome: should we give up the haemoglobin target approach? (2011) (9)
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis. (2021) (9)
The Membrane Permeability Outcome study. (2011) (9)
Low-protein diet and chronic renal failure (1991) (9)
Fludarabine, Cyclophosphamide with or without Low Dose TBI for Alternative Donor Transplants in Acquired Aplastic Anemia (SAA): A Report From the EBMT-SAA Working Party (2009) (9)
Value of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE study (2010) (9)
Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy. (1983) (8)
The renoprotective effect of combined antihypertensive drugs. (2001) (8)
The QUEST initiative anemia study in ESRD: rationale and study protocol. (2007) (8)
What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results. (2013) (8)
New approaches to treatment of secondary hyperparathyroidism. (2008) (8)
What are we expecting to learn from the MPO study? (2005) (8)
Differential morphological and functional features of fibroblasts explanted from solar lentigo (2017) (8)
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia : insight on prognostic value of DNA index in the framework of Berlin-Frnkfurt-Munster based chemotherapy (2008) (8)
Influence of membranes on morbidity. (1996) (8)
Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements (2004) (8)
Controlled study of protein-restricted diet in chronic renal failure. (1989) (8)
Management of anemia by convective treatments. (2011) (8)
Haemoglobin levels and health-related quality of life: a neglected hard end point. (2014) (8)
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study (2020) (8)
New Strategies for Anaemia Management in Chronic Kidney Disease. (2017) (8)
Effect of anaemia on left ventricular hypertrophy in end‐stage renal disease (2003) (8)
New erythropoiesis-stimulating agents: how innovative are they? (2008) (8)
Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO). (2002) (8)
Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia (2012) (8)
Polyethersulfone : membranes for multiple clinical applications (2002) (8)
High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation (2019) (8)
Clinical experience with darbepoetin-alfa (Aranesp). (2002) (7)
Primary antiphospholipid antibody syndrome with membranous obstruction of the inferior vena cava--successful PTA and thrombolytic therapy. (1998) (7)
A rationale for an individualized administration frequency of epoetin beta: a pharmacological perspective. (2002) (7)
Hema e-Chart: Italian Registry for Prospective Analysis of Epidemiology, Management and Outcome of Febrile Events in Patients with Hematological Malignancies (2010) (7)
Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism (2006) (7)
The QUEST initiative anemia study in transplant patients: rationale and study protocol. (2007) (7)
The challenging definition of naïve patient for biological drug use. (2015) (7)
Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials (2016) (7)
The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials: Clinical Epidemiology in Nephrology (2017) (7)
Anticytomegalovirus T-cell clones. (1996) (7)
Hepatitis C virus in the haemodialysis units: novel insights by new techniques? (1999) (7)
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region (2016) (7)
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia (2015) (7)
Evaluation of the Effect of Medroxyprogesterone Acetate on Bone Marrow Progenitor Cells (1991) (7)
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia (2015) (7)
Clinical practice guidelines on iron therapy: A critical evaluation (2017) (7)
Smoking habit as a risk amplifier in chronic kidney disease patients (2021) (7)
Pure red cell aplasia induced by epoetin zeta (2016) (7)
The patient with insidious chronic renal failure and the patient with the nephrotic syndrome--two manifestations of a protean and not so rare disease. (1996) (7)
Treatment of hypertension in chronic renal insufficiency. (1997) (7)
Calcium phosphate and magnesium balance in patients with acute illness (1998) (7)
New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology (2019) (7)
Influence of preparative regimen and methotrexate for GVHD prophylaxis on engraftment after related cord blood transplant for patients with hemoglobinopathies. An eurocord group analysis (2000) (7)
Pure red cell aplasia secondary to treatment with erythropoietin. (2003) (7)
TT virus infection in end-stage renal disease (ESRD). (2001) (7)
Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients? (2017) (7)
Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings (2000) (7)
Split chimerism may be enough to cure Evans syndrome (2006) (7)
Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group. (1998) (6)
Long-term haemodialysis treatment with sodium removal by convection. (1981) (6)
Stopping a medical research project for financial reasons. (2003) (6)
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease. (2020) (6)
Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients. (2014) (6)
Sodium kinetics and dialysis performances. (1988) (6)
Iron treatment and the TREAT trial (2011) (6)
Optimal phosphate control: still an unmet need in chronic kidney disease patients (2014) (6)
Dialysis: A step towards making online haemodiafiltration a gold standard (2013) (6)
Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan (2009) (6)
Debate: CON Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed? (2010) (6)
[Acute anuric glomerulonephritis]. (1970) (6)
Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa. (2013) (6)
Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia. (1991) (6)
Autologous chondrocyte transplantation. (1995) (6)
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients (2014) (6)
Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (2020) (6)
Effects of Ionized Sodium Concentrations on Ultrafiltration Rate in Peritoneal Dialysis Using Lactate and Lactate/Bicarbonate Solutions (2009) (6)
GBV-C/HGV infection in end-stage renal disease: a serological and virological survey. (2000) (6)
The management of chronic renal insufficiency in the conservative phase. (2000) (6)
Utility of immunofluorescence of urine sediment for identifying patients with renal disease due to monoclonal gammopathies. (1991) (6)
New agents to reduce cholesterol levels: implications for nephrologists. (2019) (6)
Treating anemia at different stages of renal disease. (2007) (6)
Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane. (1999) (6)
Fluid and electrolyte balance during extracorporeal therapies (1998) (6)
The modality of dialysis treatment: does it influence the response to erythropoietin treatment? (2001) (6)
Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist. (1999) (6)
Controlled trials on low-protein diet: effects on chronic renal insufficiency progression. (1993) (5)
Can chronic volume overload be recognized and prevented in hemodialysis patients? Newer methods to assess volume status. (2009) (5)
High sodium dialysate. (1979) (5)
The contribution of early nephropathy to cardiovascular risk. (2010) (5)
Urea clearance and ionic dialysance of excebrane hemodialyzers. (1999) (5)
Prospective Randomized Pilot Study on the Effects of Two Synthetic High-Flux Dialyzers on Dialysis Patient Anemia (2012) (5)
Intestinal adsorption of uraemic toxins: a new strategy for anaemia management? (2014) (5)
Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease? (2020) (5)
Method using urokinase and an antibiotic to avoid device removal in central venous catheter-related infections. (2000) (5)
Are natriuretic peptides a reliable marker for mortality in ESRD patients? (2010) (5)
Reduction in urea distribution volume over time in clinically stable dialysis patients. (2006) (5)
Comparison of second-generation screening and confirmatory assays with recombinant antigens and synthetic peptides against antibodies to hepatitis C virus: a study in renal patients. (1995) (5)
Technical-economic management models in dialytic treatment: an evolving reality. The Italian experience. (2000) (5)
Placental-blood transplantation. (1997) (5)
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis. (2020) (5)
Evaluation of dialysis outcomes: experimental versus observational evidence. (2001) (5)
Hemodialysis Induced Hypotension (1978) (5)
Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation. (1991) (5)
Color Doppler ultrasonography percutaneous transluminal angioplasty of vascular access grafts. (2007) (5)
[The Dialysis Outcomes and Practice Patterns Study (DOPPS): results of the Italian cohort]. (2005) (5)
Once weekly treatment with epoetin-β (2005) (5)
REIN follow-up trial. Ramipril Efficacy in Nephropathy. (1998) (4)
Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and Mortality (2020) (4)
Electrolyte Balancing: Modern Techniques and Outcome (2000) (4)
Morbidity and mortality on maintenance haemodialysis. (1998) (4)
Safety profile of mycophenolate mofetil: a response (2001) (4)
[Focal glomerulonephritis]. (1969) (4)
[Water quality cuts down the chronic inflammatory risk: how to obtain it and keep it over time]. (2005) (4)
Title Page. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed? (2010) (4)
Use of ACE inhibition and blood pressure management in deferring dialysis initiation. (2017) (4)
Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval? (2018) (4)
The relevance of convection in clinical practice: A critical review of the literature (2006) (4)
High-flux hemodialysis and hemodiafiltration. Impact on outcome. (2002) (4)
Application of dialysis and transplant registries to clinical practice: the Lombardy Registry. (2004) (4)
The evolution of the therapeutic approach to membranous nephropathy. (2020) (4)
Hepatitis C Virus Infection in Dialysis and Clinical Nephrology (1995) (4)
The benefits and side-effects of ramped hypertonic sodium dialysis. (1996) (4)
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression (2021) (4)
Kt/V or solute removal index: problems in measuring and interpreting the results. (1998) (4)
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients. (2018) (4)
Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (2018) (4)
Hepatitis C virus infection in kidney graft recipients: a study with second-generation assays. (1992) (4)
New therapeutic approaches in primary IgA nephropathy. (1999) (4)
Dietary compliance in patients with chronic renal failure: experience in a northern Italy trial. (1990) (4)
Adequate sodium balance and cardiovascular stability. (1990) (4)
Classical pediatric Hodgkin lymphoma in very young patients: the Italian experience (2018) (4)
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study (2021) (4)
Cardiovascular mortality in chronic kidney disease patients: potential mechanisms and possibilities of inhibition by resin-based phosphate binders (2015) (4)
Switch from a broad range of erythropoiesis stimulating agents to HX575 (biosimilar epoetin alfa): A 6-month prospective multicenter study (2011) (4)
Long-Term Peridialytic Blood Pressure Patterns in Patients Treated by Hemodialysis and Hemodiafiltration (2020) (4)
Ionic conductivity of peritoneal dialysate: a new, easy and fast method of assessing peritoneal membrane function in patients undergoing peritoneal dialysis. (2015) (3)
Anemia management in patients on peritoneal dialysis. (2012) (3)
Ethical considerations in nephro-geriatrics. (2012) (3)
Anemia in Patients with Chronic Kidney Disease not on Dialysis : Results of a Randomized Clinical Trial (2008) (3)
Lymphocyte subset reconstitution after HLA-identical placental blood transplantation (PBT) or PBT plus bone marrow transplantation (BMT) in three children with β-thalassemia major (2000) (3)
Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR. (1993) (3)
Should we really STOP treating patients with IgA nephropathy with steroids? (2018) (3)
Is the type of protein in the diet more important than its quantity for slowing progression of chronic renal insufficiency? (1997) (3)
Lessons from recent trials on hemodialysis. (2011) (3)
FP517PRELIMINARY RESULTS OF DIALYSIS STUDY: ACCURACY OF A SINGLE POOL VARIABLE-VOLUME CALCIUM KINETIC MODEL WITH DIFFERENT CALCIUM DIALYSATE CONCENTRATIONS (2015) (3)
mother donors improve outcomes after Hla haploidentical T cell-depleted hematopoietic transplantation: A Retrospective Study by the Cell Therapy and Immunobiology Working Party of the Ebmt : p076 (2016) (3)
[Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review]. (2002) (3)
Survey of supportive care standards for paediatric allogeneic stem cell transplantation patients in Europe: a first report from the EBMT Paediatric Diseases Working Party. (1996) (3)
Advanced IgA Nephropathy: To Treat or Not to Treat? (2003) (3)
AIPRI : Angiotensin-converting-enzyme inhibition in progressive renal insufficiency (1996) (3)
Current use and outcome of blood and marrow transplantation in childhood according to the Italian Registry. (1998) (3)
Is the use of subcutaneous epoetin beta once a week really equivalent to a more frequent administration of the same total dose? (2001) (3)
Epidemiology and outcome - 2 (2009) (3)
Hemodialysis fluid composition (2004) (3)
Sodium kinetics during diffusion and convection. (1983) (3)
IgM antibody response to hepatitis C virus in end-stage renal disease (1996) (3)
Membrane Compatibility, Flux and HCV Infection in Dialysis Patients: Newer Evidence (2000) (3)
[Maintenance and monitoring of water treatment system]. (2005) (3)
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors (2022) (3)
Gdansk bio-statistic and epidemiology course. (2001) (3)
[Anemia treatment to reduce mortality risk and to improve quality of life in chronic uremic patients]. (2005) (3)
Changes in dialysate composition related to new dialysis techniques. (1990) (2)
Controlled trial of plasma exchange in rapidly rogressive renal failure (1988) (2)
IgA nephropathy: remission during pregnancy and relapse in the puerperium. (1993) (2)
The effect of electrolyte balances on cardiovascular stability during hemodialysis. (1994) (2)
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. (2021) (2)
33 Safety and Efficacy of Peginesatide for Treatment of Anemia in Hemodialysis Patients Previously on Epoetin Alfa or Beta (2011) (2)
TO013PROTEINURIA REDUCTION IN IGA NEPHROPATHY BY NEFECON, A TARGETED‑RELEASE FORMULATION OF BUDESONIDE - RESULTS FROM THE NEFIGAN TRIAL (2017) (2)
Randomized trial of steroids in IgA nephropathy with moderate proteinuria at 5 years of follow up (1997) (2)
[Clinical dialysis: new problems and new prospects]. (2004) (2)
A Critical Assessment of Uremia Research (2005) (2)
Liver disease in dialysis patients. (2000) (2)
Effect of sodium pool changes on blood pressure in patients undergoing PFD: design of a prospective randomized multicenter trial. (2001) (2)
Current and future challenges in anaemia management. (2005) (2)
How Will the Results of the HEMO Study Impact Dialysis Practice? (2003) (2)
Sodium balance during extra corporeal dialysis. (2001) (2)
Efficiency parameters and treatment adequacy of hemodialysis and hemodiafiltration using polymethylmethacrylate membranes. (1999) (2)
FP488PRELIMINARY RESULTS OF DIALYSIS STUDY: SINGLE POOL VARIABLE-VOLUME CALCIUM KINETIC MODEL (2015) (2)
Effect of hemodialysis membranes on serum albumin. (2001) (2)
Membrane characteristics. (2008) (2)
C029 Hematopoietic stem cell transplantation for advanced primary MDS in children: results of a retrospective analysis from the EWOG-MDS group (2007) (2)
Sodium content and profiling. (2002) (2)
MORTALITY REDUCTION BY ONLINE-HEMODIAFILTRATION a cause-specific analysis (2018) (2)
Dialysate composition. (2008) (2)
Haemodiafiltration at Higher Volumes and Patient Survival. (2017) (2)
Hepatitis C virus infection in kidney graft recipients. (1992) (2)
THE BENEFITS AND SIDE-EFFECTS OF RAMPED HYOPERTONIC SODIUM DIALYSIS. AUTHOR'S REPLY (1996) (2)
The First European Renal Association-European Dialysis and Transplant Association CKD Anaemia Physician Behaviours Survey: key findings. (2008) (2)
Biosimilars: uncharted territory. (2007) (2)
Clinical aspects of haemodiafiltration. (2007) (2)
G-CSF in an infant donor: a method of reducing harvest volume in bone marrow transplantation. (1996) (2)
Oxidative Stress and Chronic Renal Disease - Clinical Aspects 115 (2014) (2)
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program]. (2018) (2)
Once weekly treatment with epoetin-beta. (2005) (2)
Hematocrit and Prohepcidin: Causation or Simply Association? (2006) (2)
Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study (2021) (2)
Parental origin of chromosomes 9 and 22 involved in the Ph chromosome translocation in chronic myelocytic leukemia. (1998) (2)
Glucocorticoids in the Treatment of Glomerular Diseases (2018) (2)
C030 Hematopoietic stem cell transplantation after a myeloablative conditioning regimen in children with refractory cytopenia: results of a retrospective analysis from the EWOG-MDS group (2007) (2)
MP371PREVALENCE OF HYPERKALEMIA IN DOPPS: A REAL-WORLD, INTERNATIONAL COHORT OF HEMODIALYSIS PATIENTS (2017) (2)
Biocompatibility of PMMA membranes in acute and chronic patients with renal failure. (1999) (2)
Prophylactic orchiectomy after bone marrow transplantation for boys with acute lymphoblastic leukaemia and previous testicular relapse. (1991) (2)
Nutritional Treatment and Infrequent Hemodialysis (1989) (2)
IntReALL SR 2010: An international randomised phase III study for the treatment of standard risk childhood relapsed acute lymphoblastic leukaemia (2017) (2)
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care]. (2014) (2)
Lo studio DOPPS (Dialysis Outcomes and Practice Patterns Study): risultati della coorte italiana (2005) (2)
Geographical variability of patient characteristics and treatment patterns affect outcomes for incident hemodialysis patients. (2013) (2)
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis. (2019) (1)
Opinion: Can Chronic Volume Overload Be Recognized and Prevented in Hemodialysis Patients? (1)
Successful allogeneic bone marrow transplantation in a child affected by Fanconi anemia. (1991) (1)
Steroids and immunoglobulin A nephritis. (2006) (1)
Contents Vol. 72, 1999 (2000) (1)
Low-protein diet and progression of chronic renal failure (1997) (1)
[DOPPS estimate of guideline impact on survival in hemodialysis in Italy]. (2007) (1)
Vascular access - 1 (2009) (1)
Metabolic Assessment of Acetate-Free Biofiltration (AFBF) (1989) (1)
PERITONEAL DIALYSIS 2 (2014) (1)
A reduced-intensity conditioning regimen for children with refractory cytopenia transplanted from an unrelated donor (2006) (1)
Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation. (1990) (1)
Serum calcium may not accurately predict intradialytic calcium mass transfer (2016) (1)
Clinical characteristics of patients with JMML according to mutational status (2006) (1)
Haemodialysis: Intradialytic meals: addressing a neglected problem (2017) (1)
Proceedings of the 6th Meeting of the EBMT Paediatric Diseases Working Party and 1st Meeting of the EBMT Paediatric Nurses. Introduction. (2008) (1)
Allogeneic haematopoietic stem cell transplantation in patients with haemophagocytic lymphohistiocytosis: a retrospective analysis of the Italian group for paediatric blood and marrow transplantation (AIEOP) (2007) (1)
33rd Vicenza Course on Critical Care Nephrology. Vicenza, June 9-12, 2015: Abstracts (2015) (1)
[Pharmacological prevention of kidney diseases]. (2003) (1)
[Changes in phosphocalcic metabolism in the course of periodic hemodialysis]. (1969) (1)
New perspectives in the management of secondary hyperparathyroidism. (2007) (1)
Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiency. (1989) (1)
The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease. (2022) (1)
Introduction and context: the past, present and future of CKD research. (2012) (1)
Patterns of the abstracts submitted and accepted at the Congresses of ERA-EDTA Madrid (1999) and ERA-EDTA and EKRA Nice (2000). (2001) (1)
Graft versus host disease and extracorporeal photochemotherapy: A multicenter retrospective pediatric study (2001) (1)
When Is Plasma Exchange Effective in Myeloma Renal Failure (1986) (1)
Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation (2010) (1)
More Frequent Hemoglobin ( Hb ) Measurements and Erythropoiesis-Stimulating Agent ( ESA ) Titrations are Not Associated With Increased Time in Target Hb Range (2012) (1)
[Lights and shadows on single and dual RAAS blockade]. (2010) (1)
Pancreatic beta cell function in children and adolescents after bone marrow transplantation. (1991) (1)
Colestilan for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis (2015) (1)
Survival of Diabetic Patients on Peritoneal Dialysis or Hemodialysis (1996) (1)
Allogeneic bone marrow transplantation in children from partially matched family donors. (1993) (1)
Cinacalcet for cardiovascular disease in patients undergoing dialysis. (2013) (1)
Renal anaemia - CKD 1-5 (2012) (1)
Liver Disease in Dialysis Patients (2000) (1)
REIN FOLLOW-UP TRIAL. AUTHORS' REPLY (1998) (1)
Are we approaching a new era in the treatment of anemia of chronic kidney disease patients? (2019) (1)
Chronic Kidney Disease of Unknown Cause in Agricultural Communities. (2019) (1)
DNA index has prognostic value of LLA in children treated with BFM type intense chemotherapy. Final protocol results AIEOP-LLA-94 (2007) (1)
[The use of drugs in chronic renal insufficiency: primum non nocere! (First do not harm!). The paradigmatic cases of azathioprine, metformin and denosumab]. (2016) (1)
[Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders]. (1978) (1)
PowerPoint Slides for: Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients (2017) (1)
Dialysis techniques: hemodialysis (2004) (1)
Therapy of Anemia: Is It Only a Number to Reach or Are There Other Variables to Control? (2013) (1)
Multicentre comparative trial of tienilic acid and hydrochlorothiazide in hypertensive patients (1979) (1)
Ionic Dialysance and Conductivity Modeling (2013) (1)
Adverse reaction during methylprednisolone pulse. (1992) (1)
The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials (2021) (1)
Bone marrow transplantation in children using "HLA-partially-matched" family donors. (1993) (1)
33: Similar Graft-Versus-Leukemia Effect Using Matched Unrelated Donors, Compared to HLA-Identical Siblings for Hematopoietic Stem Cell Transplantation (2008) (1)
Transplantation of peripheral blood stem cells mobilized by haematopoietic growth factors in childhood. (1998) (1)
Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross‐Sectional Study (2021) (1)
Outcome of children with all who started a search for a matched donor (1999) (1)
Anti-interferon gamma monoclonal antibody NI-0501: A new option to render allogeneic HSCT for HLH safer and more effective? (2016) (1)
Introduction: Mechanisms Determining the Ratio of Conductivity Clearance to Urea Clearance (2004) (0)
IgA nephritis: Ace inhibitors, steroids etc? Authors' reply (2007) (0)
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real (2006) (0)
CORTICOSTEROLDS IN IGA NEPHROPATHY. AUTHORS' REPLY (1999) (0)
THE PREVALENCE OF HYPERTENSION IN RECURRENT CALCIUM NEPHROLITHIASIS (1985) (0)
Effects of Haemodiafiltration of Anemia Control (2016) (0)
COMBINING DOT1L INHIBITOR EPZ-5676 WITH SORAFENIB TO TREAT MLL-REARRANGED (MLL-R) PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML) (2016) (0)
THE ONGOING MANAGEMENT OF HYPERKALAEMIA IN CHRONIC KIDNEY DISEASE PATIENTS: CASES FOR CLINICAL DECISIONS (2015) (0)
New inside the treatment of anemia of patients with chronic kidney disease (2017) (0)
[Diet therapy in preventing the progression of chronic renal insufficiency]. (1993) (0)
Electrolyte dialysance using a polyethersulfone membrane (DIAPES) in relation to urea clearance. (2003) (0)
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. (2018) (0)
[The urinary sediment in the diagnosis of chronic pyelonephritis]. (1967) (0)
[Rhythm of dialysis in every 3 weeks]. (1971) (0)
Annual Congress of the Blood Purification Management Branch of Chinese Hospital Society, August 11-14, 2016, Nanjing, China: Selected Abstracts (2017) (0)
Subject Index Vol. 72, 1996 (1996) (0)
Rebuttal: CON Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed? (2010) (0)
JAK2 gene mutation is not a common event in JMML and is not involved in the pathogenesis of the disease (2006) (0)
Role of DNA index in childhood acute lymphoblastic leukemia treated with BFM based therapy: Long term results of the AIEOP-ALL 95 (2007) (0)
Contents Vol. 93, 2003 (2003) (0)
Subject Index Vol. 116, 2010 (2010) (0)
[Sodium, potassium, calcium in chronic renal insufficiency]. (1990) (0)
Haemofiltration and haemodiafiltration (2018) (0)
Acknowledgement to Reviewers (2018) (0)
Will the results of the Proactive IV Iron Therapy in Haemodialysis Patients trial impact the anaemia guidelines? (2019) (0)
Conflicting results of hepatitis C virus serological tests in haemodialysis patients. (1993) (0)
[Evaluation of the efficacy of dialysis devices. Value and limitations of dialysance]. (1972) (0)
Contents Vol. 16, 1998 (2000) (0)
REIN follow-up trial (multiple letters) [6] (1998) (0)
Dialysate calcium concentration during calcimimetic treatment: a neglected issue (2020) (0)
[Treating anaemia in patients with chronic kidney disease: what evidence for using ESAs, after a 30-year journey?] (2020) (0)
[The use of dialysate conductivity in the sodium and urea kinetic models]. (2004) (0)
The effect of dialysis membrane on serum beta 2-microglobulin in chronic haemodialysis patients. (1997) (0)
Introduction. The role of on-line monitoring of dialysate conductivity to ensure adequate delivery of dialysis dose. (2004) (0)
RESULTS OF THE IMPLEMENTATION OF THE AIEOP RECOMMENDATIONS FOR AGAMMAGLUBOLINEMIA X-RECESSION (SLA): NATUAL HISTORY AND QUALITY OF LIFE OF 139 PATIENTS WITH XLA (2010) (0)
[Para-articular calcifications in patients undergoing periodical hemodialysis]. (1969) (0)
Renin-Angiotensin System Blockers and Acute Kidney Injury (2019) (0)
P1394ASSOCIATION BETWEEN PARATHYROID HORMONE AND MORTALITY IN HAEMODIALYSIS: THE DIABETES MAKES THE DIFFERENCE (2020) (0)
REDUCED-INTENSITY CONDITIONING FOR ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS (2004) (0)
Subject Index Vol. 69, 1995 (1995) (0)
Seizures during busulphan therapy in paediatric SCT recipents (2013) (0)
i(7)(q10) carring c.258+2T>C mutazion and risk of myeloid malignancies in patients with SDS (2009) (0)
[Glomerular permeability of plasma-proteins and therapy of nephrotic syndrome]. (1969) (0)
Response to ‘Renin–angiotensin inhibitors in stage 4 chronic kidney disease’ (2006) (0)
15th International Conference on Dialysis Advances in Chronic Kidney Disease 2013 (2013) (0)
Chronic Hemodialysis: Kt/V or Solute Removal Index to Evaluate the Effective Delivered Dose? (1998) (0)
Session I: Stem Cell Transplant Issues (2008) (0)
Expert guidance for treating anemia in chronic kidney disease: what is the appropriate drug treatment strategy? (2022) (0)
Cyclosporin A toxicity, and more: vascular endothelial growth factor (VEGF) steps forward (2004) (0)
[Semeiology of acute rejection in renal transplantation]. (1974) (0)
Genetic heterogeneity in “Familial platelet disorder/acute myelogenous leukemia” (FPD/AML) (2003) (0)
HAEMODIAFILTRATION AND MORTALITY IN END STAGE KIDNEY DISEASE PATIENTS AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (2015) (0)
[Immunosuppressive role of radiotherapy in bone marrow transplant in patients with aplastic anemia]. (1991) (0)
[KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?]. (2010) (0)
Letters and Replies (2001) (0)
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . (2009) (0)
[The long-term use of a dialysate with high sodium content in short-term hemodialysis]. (1976) (0)
Erythropoietin in kidney disease and type 2 diabetes. (2011) (0)
Under embargo until June 2 , 2014 , 09 : 30 local time ! LATE BREAKING CLINICAL TRIALS Hyperparathyroidism : Medical or Surgical Treatment ? (2014) (0)
Is Measuring Oxidative Stress, Inflammation and Tissue Damage Induced by Intravenous Iron in a Non-Clinical Model Relevant to Clinical Practice? (2012) (0)
[Possibilities of diagnosis of acetate intolerance in hemodialyzed patients without determination of serum acetate]. (1981) (0)
[Reversible anuria caused by post-partum thrombotic microangiopathy]. (1971) (0)
Monitoring of myeloid malignancies with monosomy 7 by cytogenetics and real time PCR (2005) (0)
Vascular damage and access in CKD (2012) (0)
Reduced toxicity preparative regimen with Treosulphan, Thiotepa, Fludarabie and ATG in unrelated allogeneic stem celll transplantation for tuhalassemia patients (2007) (0)
Acknowledgement to Referees (2017) (0)
Haematopoietic stem cell transplantation for sickle cell disease: an international survey on behalf of eurocord-monacord, EBMT paediatric disease working party and CIBMTR (2014) (0)
Feasibility of an Integrated Diet-Dialysis Program (IDDP) as a Treatment of ESRD (1989) (0)
One Year Experience with Hypoproteic Diet and Once a Week Hemodialysis (Less than 5 Hours) (1989) (0)
Contents Vol. 130, 2015 (2015) (0)
Nephrology Dialysis Transplantation Hepatitis C virus genotypes in chronic dialysis patients (2005) (0)
[Comparative evaluation of the dialytic efficacy of the Kill's apparatus and various filters used in the Kolff's apparatus. Preliminary report]. (1971) (0)
THE ABSENCE OF KIR ACTIVATING RECEPTORS IN DONOR NATURAL KILLER CELLS INCREASES THE RISK OF ACUTE GVHD IN UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION (2010) (0)
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease". (2008) (0)
[Do convective treatments significantly reduce morbidity and mortality?]. (2009) (0)
Contents Vol. 41, 2016 (2016) (0)
Contents Vol. 116, 2010 (2010) (0)
Cost-effectiveness analysis of online hemodiailtration versus high-lux hemodialysis (2020) (0)
Contents, Vol. 14, 1996 (1996) (0)
IgA glomerulonephritis: which is the best treatment to offer? (2008) (0)
Hyperbaric therapy (HT) in the treatment of hemorhragic cystitis (HC) after bone marrow transplantation (2000) (0)
[Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis]. (1969) (0)
Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol (2012) (0)
FP694HIGHER BMI IS ASSOCIATED WITH DECREASED VITAMIN K2 LEVELS IN HEMODIALYSIS PATIENTS (2019) (0)
Subject Index Vol. 14,1996 (1996) (0)
Contents Vol. 113, 2009 (2009) (0)
Recipient CTLA-4 genotype is a prognostic factor for acute GvHD in hematopoietic stem cell transplantation for thalassemia (2009) (0)
On Peginesatide and Anemia Treatment in CKD (2013) (0)
[Cerebral complications related to deobstruction of Scribner shunts]. (1970) (0)
Contents, Vol. 69, 1995 (1995) (0)
Decision making in high risk adult thalassemia patients undergoing unrelated bone marrow transplantation: Quality of life, motivation and communication factors, ethical issues (2005) (0)
Status of DOPPS in 12 Countries Research on Vascular Access Abstracts and Presentations Worldwide Questions and Answers (2002) (0)
[Lombardy regional registry for the replacement treatment in chronic renal insufficiency. Problems and prospects]. (1989) (0)
pidemiology and Prevention of Cardiovascular omplication in Chronic Kidney Disease Patients (2004) (0)
[Innovations in dialytic therapy and daily clinical problems: anemia]. (2004) (0)
Bone disease - 2 (2009) (0)
[Pathogenetic hypothesis concerning intradialytic hyperpyrexia]. (1974) (0)
6. Management of anemia by convective treatments and vitamin E coated membranes (2016) (0)
[Clinical significance of the determination of beta lc globulin in the nephrotic syndrome. Preliminary observations]. (1968) (0)
Oral Sessions and Working Parties (2006) (0)
[The CROFF pavilion at the Policlinico Hospital in Milan: the beginnings]. (2020) (0)
Subject Index Vol. 16, 1996 (1996) (0)
Change in Albuminuria and GFR Slope as Joint Surrogate Endpoints for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD. (2023) (0)
[How to slow the progression of kidney damage today. Chronic kidney disease: an important personal, family and social problem]. (2012) (0)
The treatment of IgA nephropathy. (2000) (0)
Stem cell factor and interleukin-6, alone or in combination with granulocyte colony-stimulating factor, do not affect the growth of solid tumor cell lines. (1995) (0)
[Metabolic and dietetic problems of infantile chronic renal insufficiency]. (1969) (0)
Anemia: A Connection Between Heart Failure and Kidney Failure. (2021) (0)
Correction of severe primary immunodeficiencies by bone marrow transplantation: report from the the Italian Association of Haematology and Oncology (AIEOP) registry (2005) (0)
[Epidemiology and demography of uremia: data from the Lombardy Dialysis and Transplantation Registry (RLDT)]. (2005) (0)
A new paradigm in treating patients with chronic kidney disease and anaemia after a journey lasting more than 35 years. (2021) (0)
International conference on dialysis III (2001) (0)
The new Research Agenda and Public Health interface: a framework for improving care. (2012) (0)
[Nephrologist's behaviours and perceptions on sideropenic anemia's diagnosis and treatment for conservative phase nephropatic patient intolerant or not responding to oral iron therapy]. (2013) (0)
Acknowledgement to referees (2006) (0)
[Behavior of body weight, blood volume, blood pressure values and heart rate during ultrafiltration and iso-osmotic dialysis]. (1979) (0)
IgM antibody response to hepatitis C virus in end-stage renal disease. (1996) (0)
DOPPS Investigators recognized with the Belding H. Scribner Award (2004) (0)
[Sisomicin in the treatment of urinary infections in high-risk patients]. (1981) (0)
SP551RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS (RAASI) AND CLINICAL OUTCOMES IN HEMODIALYSIS PATIENTS: RESULTS FROM THE DOPPS (2017) (0)
Gastrointestinal steroid refractory GvHD in children successfully treated with mesenchymal stromal cells cannot be solely assessed by clinical response (2010) (0)
Chapter 28. Vitamin D: Production, Metabolism, Mechanism of Action, and Clinical Requirements (2008) (0)
Mutations in the 5'UTR region of the Hsp 70-1 gene appear to condition the response to extracorporeal photochemotherapy (2001) (0)
Characteristics and Outcome of Therapy-Related MDS Developing after Primary Cancer in Children. (2005) (0)
Chapter 29. Erythropoietin and Iron Therapy in Patients with Renal Failure (2010) (0)
Subject Index Vol. 31, 2010 (2010) (0)
In order to improve CKD – MBD outcomes , in 2003 , the National Kidney Foundation launched the Kidney Dialysis (2012) (0)
MP385RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR PRESCRIPTION PATTERNS IN HEMODIALYSIS PATIENTS: RESULTS FROM THE INTERNATIONAL DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS) (2017) (0)
[Cephalothin: its uses in nephrology]. (1967) (0)
Annual Congress of the Chinese Blood Purification Center Administration Committee. August 20-22, 2015, Tianjin, China: Abstracts (2016) (0)
Impact of haemoglobin and erythropoietin dose changes on mortality : a secondary analysis of results from a randomized anaemia management trial (0)
Subject Index Vol. 113, 2009 (2009) (0)
The presence of activating killer immunoglobulin-like receptors on donor natural killer cells is critical to the successful outcome of unrelated donor allogeneic haematopoietic stem cell transplantation for thalassaemia (2011) (0)
[Interview with Prof. Francesco Locatelli: an international nephrologist of all seasons by Timio Mario]. (2011) (0)
FP378ASSOCIATION OF OUTCOMES AND MAINTENANCE OF TARGET HB LEVELS IN CKD PATIENTS: FINDINGS FROM A POOLED ANALYSIS OF 23 PROSPECTIVE STUDIES (2015) (0)
FP402RELATIVE RISK OF MORTALITY IN HEMODIALYSIS PATIENTS PRESCRIBED CALCIUM-FREE AND CALCIUM-CONTAINING PHOSPHATE BINDING AGENTS (2015) (0)
[Indications for associated renal revascularization]. (2002) (0)
SAT0491 Clinical features and complications in a large international cohort of antimda5 patients: a challenge for the future (2018) (0)
Comparison between an artificial neural network and logistic regression in predicting acute graft versus host disease following unrelated bone marrow transplantation in thalassemia patients (2010) (0)
Dialysis dose and mortality: where is the limit? (2021) (0)
FP678IMPACT OF EUROPEAN MEDICINES AGENCY RECOMMENDATIONS FOR ALLERGIC REACTIONS TO INTRAVENOUS IRON-CONTAINING DRUGS IN DIALYSIS CENTERS OF LOMBARDY REGION (2015) (0)
FP690HAEMODIAFILTRATION AND MORTALITY IN END STAGE KIDNEY DISEASE PATIENTS AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (2015) (0)
Consultants for the American Journal of Nephrology 1996 (1996) (0)
CKD BONE DISEASE (2014) (0)
Association between specific HLA combination and probability of acute graft versus host desease in bone marrow transplantation (2001) (0)
Vitamin K2 is a key regulator of clinically relevant molecular processes (2020) (0)
Nephropathy in Patients With Chronic Kidney Disease'' Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Letter Regarding Article by Solomon et al, ''Cardiac Angiography in REnally Impaired (2012) (0)
CONDITIONING SYSTEM BASED ON THE USE OF TREOSULFAN FOR ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH THALASSEMIA MAJOR (2008) (0)
Steroids and immunoglobulin A nephritis. Authors' reply (2006) (0)
Lab methods, progression & risk factors for CKD - 3 (2009) (0)
MP344THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY (2016) (0)
[Study of the hypouricemic effect of benziodarone in chronic renal insufficiency]. (1967) (0)
Original Haemodia ﬁ ltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials (2016) (0)
Contents Vol. 31, 2010 (2010) (0)
[Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications]. (2007) (0)
Hypoxia-Inducible Factor–Prolyl Hydroxyl Domain Inhibitors: From Theoretical Superiority to Clinical Noninferiority Compared with Current ESAs? (2022) (0)
Special Feature Dialysis dose and frequency (2005) (0)
Kelfiprim versus co-trimoxazole in recurrent and persistent urinary tract infections: multicenter double-blind trial. (1987) (0)
Literature abstracts (2004) (0)
CALM-AF10 not an unfavorable prognostic factor in children with acute lineage-t lymphoblastic leukemia (ALL-T) treated with I protocols AIEOP LLA-2000 and LLA-R-2006 (2010) (0)
SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE (2017) (0)
A comparison of cytotoxic T lymphocyte precursor frequencies in responder/stimulator pairs with increasing degrees of mismatch (2001) (0)
DIALYSIS. EXTRACORPOREAL DIALYSIS: TECHNIQUES AND ADEQUACY FP473 THE USE OF HIGH-FLUXMEMBRANES IS NOTASSOCIATED WITH IMPROVED SURVIVALOF PATIENTS ON HEMODIALYSIS (2015) (0)
Hyperkalemia excursions and risk of mortality and hospitalizations in hemodialysis patients: results from DOPPS-Italy (2022) (0)
The role of thoraco-abdominal irradiation before marrow transplantation. (1991) (0)
Contents Vol. 128, 2014 (2015) (0)
Chronic Kidney Disease-Associated Pruritus: From Epidemiology to Treatment (2021) (0)
Bioprosthesis: a new approach with loop vascular access in hemodialysis patients (1999) (0)
[Treatment with methylprednisolone boli in nephrotic syndrome caused by glomerular pathology with minimal histological lesions]. (1981) (0)
Contents, Vol. 64,1993 (1993) (0)
Contents Vol. 43, 2017 (2017) (0)
[The quality of dialysis water]. (2004) (0)
[Uratic retention due to chronic renal failure. Therapeutic treatment with benziodarone]. (1969) (0)
FP473THE USE OF HIGH-FLUX MEMBRANES IS NOT ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS ON HEMODIALYSIS (2015) (0)
Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratio: A Novel Markers of Inflammation in Chronic Haemodialysis Patients (2014) (0)
The treatment of membranous nephropathy: a journey in the search for evidence (2022) (0)
A prospective study on 136 patients with agammaglobulinemia X-recessive: results from the italian primary immunodeficiencies network (2008) (0)
Donor-recipient status for HLA class I ligands and not the KIR genotype, is predictive of unrelated hsct outcome in beta-thalassemia patients (2007) (0)
Anaemia ERBP Position statement. Author's reply (2009) (0)
Nephrology Dialysis Transplantation Ionic dialvsance as a method for the on-line monitoring of delivered dialysis without blood sampling (2005) (0)
Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution (2021) (0)
[Use of dialysate conductivity to obtain neutral sodium balance in chronic hemodialysis patients]. (2005) (0)
FP377ASSOCIATION OF OUTCOMES AND HB LEVELS IN CKD PATIENTS: FINDINGS FROM A POOLED ANALYSIS OF 24 PROSPECTIVE STUDIES (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Francesco Locatelli?

Francesco Locatelli is affiliated with the following schools:

Francesco Locatelli's Academic­Influence.com Rankings